Achiko AG (Achiko AG) Accounts Payable : $2.60 Mil (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Accounts Payable?

Achiko AG's Accounts Payable for the quarter that ended in Jun. 2022 was $2.60 Mil.

Achiko AG's quarterly Accounts Payable increased from Jun. 2021 ($2.22 Mil) to Dec. 2021 ($2.27 Mil) and increased from Dec. 2021 ($2.27 Mil) to Jun. 2022 ($2.60 Mil).

Achiko AG's annual Accounts Payable declined from Dec. 2019 ($2.22 Mil) to Dec. 2020 ($2.02 Mil) but then increased from Dec. 2020 ($2.02 Mil) to Dec. 2021 ($2.27 Mil).

Achiko AG Accounts Payable Historical Data

The historical data trend for Achiko AG's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Accounts Payable Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Accounts Payable

1.85

2.22

2.02

2.27

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Accounts Payable	Get a 7-Day Free Trial			2.06	2.02	2.22	2.27	2.60

Achiko AG Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Achiko AG Accounts Payable Related Terms

Thank you for viewing the detailed overview of Achiko AG's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.